ArticleResearch and practice in thrombosis and haemostasis2017

Safety, pharmacokinetics and pharmacodynamics of idarucizumab, a specific dabigatran reversal agent in healthy Japanese volunteers: a randomized study.

Masahiro Yasaka et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.